CARsgen Therapeutics Holdings Ltd. Financial Overview
CARsgen Therapeutics Holdings Ltd.'s market cap is currently HK$9.02B. The company's EPS TTM is HK$-0.15288733180000003; its P/E ratio is -15.42; CARsgen Therapeutics Holdings Ltd. is scheduled to report earnings on August 15, 2025, and the estimated EPS forecast is HK$-0.15. See an overview of income statement, balance sheet, and cash flow financials.
